Summary

The next-generation sequencing market is expected to reach USD 29.53 billion in 2030, up from USD 14.94 billion in 2025, at a CAGR of 14.6% during the forecast period. The growing application of NGS in oncology, infectious diseases, reproductive health, metagenomics, and personalized medicine is the primary driver of market expansion. Meanwhile, advanced bioinformatics tools for data analysis and interpretation are facilitating the use of NGS, thereby helping a wider user base adopt the technique.

https://mnmimg.marketsandmarkets.com/Images/next-generation-sequencing-ngs-technologies-market1-img-overview.webp

“Consumables accounted for the largest share of the product segment in the NGS market in 2024.”
The NGS products market is segmented into consumables, platforms, and bioinformatics tools. In 2024, consumables held the largest share. This segment includes reagents, library preparation kits, sequencing flow cells, and sample preparation kits, which are used in high volumes across many applications. Demand remains robust because consumables are purchased repeatedly, unlike instruments, which are generally one-time investments. The growing use of targeted sequencing and custom panels is also driving demand for specialized, application-specific consumables. Furthermore, an expanding user base and ongoing improvements in sequencing chemistries are drawing more customers toward consumables to simplify their workflows and improve data quality.
?
“The academic & research institutes segment accounted for the largest share by services end-user segment in the next-generation sequencing market in 2024.”
The next-generation sequencing services market is segmented by end user into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & clinical laboratories, and other users. In 2024, academic and research institutes held the largest share. This leadership is supported by strong government and private funding for research programs, enabling higher spending on NGS-related needs, including instruments and consumables. Pharmaceutical and biotechnology companies represented the second-largest end-user segment in the market.
“The Asia Pacific region will grow at the highest CAGR from 2025 to 2030.”
The Asia Pacific region is estimated to be the fastest-growing segment of the market, owing to large-scale population genomics projects and rising demand for precision medicines. Additionally, the rising prevalence of rare and genetic diseases is attributed to the aging populations in countries such as Japan and China. These factors are supporting the adoption of sequencing technologies in healthcare management and treatment, driving market growth.

The primary interviews conducted for this report can be categorized as follows:

? By Respondent: Supply Side- 70% and Demand Side 30%
? By Designation: Managers - 45% CXOs and Director-level - 30%, and Executives - 25%,
? By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5%, and Middle East -5%.

List of Companies Profiled in the Report:
? Illumina, Inc. (US)
? Thermo Fisher Scientific Inc. (US)
? F. Hoffmann-La Roche Ltd. (Switzerland)
? Danaher Corporation (US)
? QIAGEN (Netherlands)
? Agilent Technologies, Inc. (US)
? Revvity (US)
? Eurofins Scientific (Luxembourg)
? PacBio (US)
? Oxford Nanopore Technologies plc. (UK)
? Takara Bio Inc. (Japan)
? BGI Group (China)
? Merck KGaA (Germany)
? BD (US)
? 10X Genomics (US)
? New England Biolabs (US)
? Promega Corporation (US)
? Novogene Co., Ltd. (China)
? LGC Limited (UK)
? WuXi Biologics (China)
? MGI Tech Co. Ltd. (China)
? Tecan Trading AG (Switzerland)
? Twist Biosciences (US)
? Azenta US, Inc. (US)
? GenScript (US)
? SD Biosensor, Inc. (South Korea)
? Fulgent Genetics (US)
? Hamilton Company (US)
? Zymo Research Corporation (US)
? NeoGenomics Laboratories (US)
? Psomagen (US)

Research Coverage:
The scope of the report covers detailed information on the major factors, such as drivers, challenges, opportunities, and restraints, that influence the growth of the NGS market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, product and service portfolio, key strategies such as product and service launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the NGS market. Competitive analysis of top players and upcoming startups in the NGS market ecosystem is also covered in this report.
Key Benefits of Buying the Report:
The report will help market leaders and new entrants by providing the closest approximations of revenue for the overall NGS market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain insights to better position their business and develop suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights into the following points:
Analysis of key drivers (advancements in sequencing platforms, rising clinical applications of sequencing, growing demand for precision medicine, declining sequencing costs), restraints (complex data analysis, high initial capital investment), opportunities (integration of AI and ML, adoption of long-read sequencing technologies, emphasis on multiomics integration), and challenges (standardization issues) influencing the growth of the market.
? Product Development/Innovation: Detailed insights on newly launched products/services of the next-generation sequencing market
? Market Development: Comprehensive information about lucrative markets - the report analyzes the market across varied regions
? Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the next-generation sequencing market
? Competitive Assessment: Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), Revvity (US), Eurofins Scientific (Luxembourg), PacBio (US), Oxford Nanopore Technologies plc. (UK), Takara Bio Inc. (Japan), BGI Group (China), Merck KGaA (Germany), BD (US), 10X Genomics (US), New England Biolabs (US), Promega Corporation (US), Novogene Co., Ltd. (China), LGC Limited (UK), WuXi Biologics (China), MGI Tech Co. Ltd. (China), Tecan Trading AG (Switzerland), Twist Biosciences (US), Azenta US, Inc. (US), GenScript (US), SD Biosensor, Inc. (South Korea), Fulgent Genetics (US), Hamilton Company (US), Zymo Research Corporation (US), NeoGenomics Laboratories (US), and Psomagen (US)

ページTOPに戻る

Table of Contents

1 INTRODUCTION 58
1.1 STUDY OBJECTIVES 58
1.2 MARKET DEFINITION 58
1.3 STUDY SCOPE 59
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 59
1.3.2 INCLUSIONS & EXCLUSIONS 60
1.4 YEARS CONSIDERED 61
1.5 CURRENCY CONSIDERED 61
1.6 STAKEHOLDERS 62
1.7 SUMMARY OF CHANGES 62
2 EXECUTIVE SUMMARY 63
2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 63
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 64
2.3 DISRUPTIVE TRENDS IN NEXT-GENERATION SEQUENCING MARKET 65
2.4 HIGH-GROWTH SEGMENTS 66
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 67
3 PREMIUM INSIGHTS 68
3.1 NEXT-GENERATION SEQUENCING MARKET OVERVIEW 68
3.2 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET,
BY OFFERING AND COUNTRY 69
3.3 NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY 70
3.4 NEXT-GENERATION SEQUENCING MARKET, BY OFFERING, 2026 VS. 2031 (%) 70
4 MARKET OVERVIEW 71
4.1 INTRODUCTION 71
4.2 MARKET DYNAMICS 71
4.2.1 DRIVERS 72
4.2.1.1 Advancements in sequencing platforms 72
4.2.1.2 Rising clinical applications of sequencing 73
4.2.1.3 Growing demand for precision medicine 73
4.2.1.4 Declining costs of sequencing 73
4.2.2 RESTRAINTS 74
4.2.2.1 Data analysis complexity 74
4.2.2.2 High capital investments and expenses 74
4.2.3 OPPORTUNITIES 74
4.2.3.1 Integration of AI and ML 74
4.2.3.2 Adoption of long-read sequencing technologies 75
4.2.3.3 Emphasis on multiomics integration 75
4.2.4 CHALLENGES 76
4.2.4.1 Standardization issues 76
4.3 UNMET NEEDS AND WHITE SPACES 76
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 76
4.5 STRATEGIC MOVIES BY TIER 1/2/3 PLAYERS 77
5 INDUSTRY TRENDS 78
5.1 PORTER’S FIVE FORCES ANALYSIS 78
5.1.1 INTENSITY OF COMPETITIVE RIVALRY 79
5.1.2 BARGAINING POWER OF SUPPLIERS 79
5.1.3 BARGAINING POWER OF BUYERS 80
5.1.4 THREAT FROM SUBSTITUTES 80
5.1.5 THREAT FROM NEW ENTRANTS 80
5.2 MACROECONOMIC OUTLOOK 80
5.2.1 INTRODUCTION 80
5.2.2 GDP TRENDS AND FORECAST 81
5.2.3 R&D TRENDS IN GLOBAL HEALTHCARE INDUSTRY 81
5.2.4 R&D TRENDS IN GLOBAL BIOTECH INDUSTRY 82
5.3 VALUE CHAIN ANALYSIS 82
5.4 ECOSYSTEM ANALYSIS 83
5.4.1 ROLE OF PLAYERS IN ECOSYSTEM 85
5.5 PRICING ANALYSIS 86
5.5.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER 86
5.5.1.1 Average selling price trend of platforms, by key player 86
5.5.1.2 Average selling price trend of consumables, by key player 87
5.5.2 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER 88
5.5.3 AVERAGE SELLING PRICE TREND, BY REGION 89
5.6 TRADE ANALYSIS 90
5.6.1 IMPORT SCENARIO (HS CODE 382200) 91
5.6.2 EXPORT SCENARIO (HS CODE 382200) 93
5.6.3 IMPORT SCENARIO (HS CODE 902700) 95
5.6.4 EXPORT SCENARIO (HS CODE 902700) 97
5.7 KEY CONFERENCES & EVENTS, 2026?2027 99
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 100
5.9 INVESTMENT & FUNDING SCENARIO 100
5.10 CASE STUDY ANALYSIS 101
5.10.1 COMPREHENSIVE GENOMIC PROFILING TEST EXPANDS PRECISION ONCOLOGY APPLICATIONS 101
5.10.2 ULTRA-SENSITIVE NGS PANEL ENABLES MEASURABLE RESIDUAL DISEASE MONITORING 102
5.10.3 NGS-BASED MYELOID FUSION PANEL ENHANCES HEMATOLOGIC MALIGNANCY RESEARCH 102
5.11 IMPACT OF 2025 US TARIFF ON NEXT-GENERATION SEQUENCING MARKET 102
5.11.1 INTRODUCTION 102
5.11.2 KEY TARIFF RATES 103
5.11.3 PRICE IMPACT ANALYSIS 104
5.11.4 IMPACT ON COUNTRY/REGION 104
5.11.4.1 US 104
5.11.4.2 Europe 105
5.11.4.3 Asia Pacific 105
5.11.5 IMPACT ON END-USE INDUSTRIES 105
5.11.5.1 Pharmaceutical & biotechnology companies 106
5.11.5.2 CROs and academic & research institutes 106
5.11.5.3 Hospitals, diagnostic laboratories, and clinics 106
6 CUSTOMER LANDSCAPE & BUYER BEHAVIOUR 107
6.1 DECISION-MAKING PROCESS 107
6.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 107
6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 107
6.2.2 KEY BUYING CRITERIA FOR NGS PRODUCTS, BY END USER 108
6.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 109
6.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 109
7 SUSTAINABILITY AND REGULATORY LANDSCAPE 111
7.1 REGIONAL REGULATIONS AND COMPLIANCE 111
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
7.1.2 INDUSTRY STANDARDS 113
7.1.2.1 North America 113
7.1.2.2 Europe 114
7.1.2.3 Asia Pacific 114
7.1.2.4 Rest of the world 115
7.2 SUSTAINABILITY INITIATIVES 115
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 115
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 116
8 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 118
8.1 TECHNOLOGY ANALYSIS 118
8.1.1 KEY TECHNOLOGIES 118
8.1.1.1 Sequencing by synthesis 118
8.1.1.2 Ion semiconductor sequencing 118
8.1.1.3 Nanopore sequencing 119
8.1.1.4 Single-molecule real-time sequencing (SMRT) 119
8.1.2 COMPLEMENTARY TECHNOLOGIES 120
8.1.2.1 Automated sample preparation systems 120
8.1.2.2 Bioinformatics and data analysis platforms 120
8.1.2.3 CRISPR-based targeted sequencing 121
8.1.2.4 Multiplex PCR 121
8.1.3 ADJACENT TECHNOLOGIES 121
8.1.3.1 Single-cell sequencing technology 121
8.1.3.2 Multiomics integration 122
8.1.3.3 Spatial genomics and transcriptomics 122
8.1.3.4 Gene editing technologies 122
8.2 TECHNOLOGY ROADMAP 123
8.3 PATENT ANALYSIS 123
8.3.1 METHODOLOGY 123
8.3.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE 124
8.3.3 LIST OF KEY PATENTS 125
8.4 FUTURE APPLICATIONS 125
8.5 IMPACT OF AI/GEN AI ON NEXT-GENERATION SEQUENCING MARKET 126
8.5.1 TOP USE CASES AND MARKET POTENTIAL 127
8.5.2 BEST PRACTICES IN AI-ENABLED NGS WORKFLOWS 128
8.5.3 CASE STUDIES OF AI IMPLEMENTATION IN NEXT-GENERATION SEQUENCING MARKET 128
8.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 128
8.5.5 CLIENTS’ READINESS TO ADOPT AI-INTEGRATED SEQUENCING SOLUTIONS IN NEXT-GENERATION SEQUENCING MARKET 129
9 NEXT-GENERATION SEQUENCING MARKET, BY OFFERING 130
9.1 INTRODUCTION 131
9.2 PRODUCTS 131
9.2.1 DEMAND FOR CONSUMABLES AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET 131
9.3 SERVICES 134
9.3.1 SHIFT TOWARD SERVICE-BASED MODELS TO DRIVE MARKET 134
10 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY TYPE 138
10.1 INTRODUCTION 139
10.2 CONSUMABLES 139
10.2.1 LIBRARY PREPARATION KITS & REAGENTS 143
10.2.1.1 Strong demand and growing applications to ensure market growth 143
10.2.2 SEQUENCING KITS & REAGENTS 147
10.2.2.1 Focus on technological advancements to support market growth 147
10.2.3 OTHER CONSUMABLES 151
?
10.3 PLATFORMS 154
10.3.1 SEQUENCING PLATFORMS 157
10.3.1.1 Need for advanced technologies to decode genetic information to drive market 157
10.3.1.2 Illumina 160
10.3.1.2.1 NovaSeq Series (X/X Plus) 161
10.3.1.2.1.1 Next-generation ultra-high throughput sequencing to enable large-scale genomics 161
10.3.1.2.2 MiSeq/MiSeq i100 162
10.3.1.2.2.1 Compact sequencing platforms to enable rapid and targeted genomic analysis 162
10.3.1.2.3 NextSeq 1k/2K and 550 163
10.3.1.2.3.1 Mid-throughput sequencing systems to support diverse research and clinical applications 163
10.3.1.2.4 NovaSeq 6000 164
10.3.1.2.4.1 High-throughput sequencing platform to enable large-scale genomic studies 164
10.3.1.3 Thermo Fisher Scientific 165
10.3.1.4 PacBio 166
10.3.1.4.1 Revio 167
10.3.1.4.1.1 High-throughput long-read sequencing to support market growth 167
10.3.1.4.2 Sequel II/IIe 168
10.3.1.4.2.1 High-accuracy, long-read sequencing to support market growth 168
10.3.1.4.3 Vega Seq 169
10.3.1.4.3.1 Benchtop long-read sequencing platform to support market growth 169
10.3.1.5 Oxford Nanopore Technologies 170
10.3.1.6 Other sequencing platforms 170
10.3.2 LIBRARY PREPARATION PLATFORMS 171
10.3.2.1 Rising demand for sequencing in clinical applications to drive market 171
10.4 BIOINFORMATICS TOOLS 174
10.4.1 DATA ANALYSIS SOFTWARE & WORKBENCHES 178
10.4.1.1 Demand for genome analysis in clinical diagnostics to support market growth 178
10.4.2 DATA VISUALIZATION TOOLS 182
10.4.2.1 Rising demand for sequencing-based research to support market growth 182
10.4.3 OTHER BIOINFORMATICS TOOLS 185
11 NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TECHNOLOGY 188
11.1 INTRODUCTION 189
11.2 SEQUENCING BY SYNTHESIS 190
11.2.1 HIGH, RAPID PRODUCTION OF BASE PAIRS TO SUPPORT ADOPTION 190
?
11.3 ION SEMICONDUCTOR SEQUENCING 194
11.3.1 SIMPLER WORKFLOW AND COST-EFFECTIVENESS TO SUPPORT MARKET GROWTH 194
11.4 SMRT SEQUENCING 198
11.4.1 FOCUS ON RAPID RESULTS AND LOWER SEQUENCING COSTS TO DRIVE MARKET 198
11.5 NANOPORE SEQUENCING 201
11.5.1 EMPHASIS ON DIRECT RNA SEQUENCING CAPABILITIES TO PROPEL DEMAND 201
11.6 OTHER SEQUENCING TECHNOLOGIES 205
12 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY WORKFLOW 209
12.1 INTRODUCTION 210
12.2 SEQUENCING 210
12.2.1 ABILITY TO ADDRESS COMPLEX GENOMIC REGIONS AND RESOLVE STRUCTURAL VARIATIONS TO DRIVE MARKET 210
12.3 PRESEQUENCING 214
12.3.1 INCREASED RESEARCH AND SUPPLY AGREEMENTS BETWEEN INDUSTRY PARTICIPANTS TO DRIVE MARKET 214
12.4 DATA ANALYSIS 218
12.4.1 RISE OF IN-HOUSE INSTALLATION OF BIOINFORMATICS INFRASTRUCTURE TO DRIVE MARKET 218
13 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY END USER 222
13.1 INTRODUCTION 223
13.2 ACADEMIC & RESEARCH INSTITUTES 223
13.2.1 RISING RESEARCH INTENSITY FOR GENOME RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH 223
13.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 227
13.3.1 RISING DEMAND FOR COMPREHENSIVE SEQUENCING DATA IN GENETIC RESEARCH TO DRIVE MARKET 227
13.4 CLINICAL & DIAGNOSTIC LABORATORIES 231
13.4.1 INCREASED APPLICATIONS IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE MARKET GROWTH 231
13.5 OTHER END USERS 234
14 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE 238
14.1 INTRODUCTION 239
14.2 SEQUENCING SERVICES 239
14.2.1 EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS 243
14.2.1.1 Advancements in target enrichment technologies to drive market 243
14.2.2 RNA SEQUENCING SERVICES 247
14.2.2.1 Launch of RNA services and availability of diverse RNA bioinformatics tools to drive market 247
?
14.2.3 DE NOVO SEQUENCING SERVICES 250
14.2.3.1 Need for more accurate and faster characterization than traditional methods to drive market 250
14.2.4 CHIP SEQUENCING SERVICES 253
14.2.4.1 Surge in demand from academic and research institutes to drive market 253
14.2.5 WHOLE-GENOME SEQUENCING SERVICES 257
14.2.5.1 Technological advancements in next-generation sequencing products to drive market 257
14.2.6 METHYL SEQUENCING SERVICES 260
14.2.6.1 Large-scale adoption in cancer research to drive market 260
14.2.7 OTHER SEQUENCING SERVICES 264
14.3 PRESEQUENCING SERVICES 267
14.3.1 LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES 270
14.3.1.1 Development of advanced library preparation solutions to drive market 270
14.3.2 SAMPLE PREPARATION SERVICES 274
14.3.2.1 Applicability in oncology, infectious diseases, metagenomics, and epigenetics to drive market 274
14.3.3 QUALITY CONTROL SERVICES 277
14.3.3.1 Growing research activities using next-generation sequencing technology to drive market 277
14.4 BIOINFORMATICS & DATA ANALYSIS SERVICES 280
14.4.1 DATA ANALYSIS SERVICES 284
14.4.1.1 Increasing demand for precision and speed in genomics for clinical diagnosis to drive market 284
14.4.2 DATA VISUALIZATION & INTERPRETATION SERVICES 288
14.4.2.1 Rising demand for sequencing-based research to drive market 288
14.4.3 DATA STORAGE & MANAGEMENT SERVICES 291
14.4.3.1 Need for effective data management to drive market 291
14.5 NGS PLATFORM SERVICES 294
14.5.1 COMPLIANCE WITH STRINGENT QUALITY AND OPERATIONAL REQUIREMENTS TO DRIVE MARKET 294
15 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY WORKFLOW 298
15.1 INTRODUCTION 299
15.2 SEQUENCING 299
15.2.1 RISING DEMAND FOR SEQUENCING SERVICES AND APPLICATIONS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH 299
15.3 PRESEQUENCING SERVICES 303
15.3.1 CUSTOM DEVELOPMENT OF SAMPLES FOR SEQUENCING TO BOOST MARKET GROWTH 303
15.4 DATA ANALYSIS SERVICES 306
15.4.1 RISING DEMAND FOR ADVANCED RESEARCH TO DRIVE MARKET 306
16 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER 310
16.1 INTRODUCTION 311
16.2 ACADEMIC & RESEARCH INSTITUTES 311
16.2.1 GROWING RESEARCH INTENSITY TO SUPPORT MARKET GROWTH 311
16.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 315
16.3.1 RISING DEMAND FOR COMPREHENSIVE GENETIC DATA TO DRIVE GROWTH 315
16.4 HOSPITALS & CLINICAL LABORATORIES 318
16.4.1 INCREASED APPLICATION IN NGS IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE GROWTH 318
16.5 OTHER END USERS 322
17 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION 326
17.1 INTRODUCTION 327
17.2 DIAGNOSTICS 327
17.2.1 CANCER DIAGNOSTICS 331
17.2.1.1 Rising demand for targeted therapies to drive market 331
17.2.2 INFECTIOUS DISEASE DIAGNOSTICS 335
17.2.2.1 Rising demand for comprehensive genomic data in clinical diagnostics to propel growth 335
17.2.3 REPRODUCTIVE HEALTH DIAGNOSTICS 338
17.2.3.1 Focus on genetic disease diagnostics to drive growth 338
17.2.4 OTHER DIAGNOSTIC APPLICATIONS 342
17.3 DRUG DISCOVERY & DEVELOPMENT 345
17.3.1 PHARMACOGENOMICS 348
17.3.1.1 Rising use of NGS for understanding genomic variants in humans to drive growth 348
17.3.2 OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS 352
17.4 AGRICULTURE & ANIMAL RESEARCH 355
17.4.1 EMPHASIS ON IMPROVING CROP PRODUCTIVITY TO DRIVE ADOPTION OF NGS 355
17.5 OTHER APPLICATIONS 358
18 NEXT-GENERATION SEQUENCING MARKET, BY REGION 362
18.1 INTRODUCTION 363
18.2 NORTH AMERICA 363
18.2.1 US 372
18.2.1.1 Rapid growth and advancements to lead market 372
18.2.2 CANADA 379
18.2.2.1 Increasing government initiatives in sequencing research to boost market growth 379
18.3 EUROPE 386
18.3.1 GERMANY 393
18.3.1.1 Adoption of advanced sequencing technologies to drive market 393
?
18.3.2 UK 400
18.3.2.1 Strategic initiatives and funding for genomics research to support market growth 400
18.3.3 FRANCE 407
18.3.3.1 Increasing government investment in genomics research to drive growth 407
18.3.4 ITALY 414
18.3.4.1 Favorable funding scenario to drive adoption of advanced sequencing technology 414
18.3.5 SPAIN 421
18.3.5.1 Growing focus on advancements in personalized medicine to support market growth 421
18.3.6 NETHERLANDS 428
18.3.6.1 Well-established research infrastructure to sustain demand for NGS 428
18.3.7 REST OF EUROPE 435
18.4 ASIA PACIFIC 443
18.4.1 CHINA 451
18.4.1.1 Favorable regulatory reforms to drive market 451
18.4.2 JAPAN 458
18.4.2.1 Rising number of collaborations in NGS to drive market 458
18.4.3 INDIA 465
18.4.3.1 Government and private initiatives for genomics projects to propel market 465
18.4.4 AUSTRALIA 472
18.4.4.1 Increased genetic research in Australia to support market growth 472
18.4.5 SOUTH KOREA 479
18.4.5.1 Demand for advanced sequencing technologies to support market 479
18.4.6 REST OF ASIA PACIFIC 486
18.5 LATIN AMERICA 494
18.5.1 BRAZIL 501
18.5.1.1 Increased government investments in genomics advancements to drive market 501
18.5.2 MEXICO 507
18.5.2.1 Rising demand for chronic disease treatment to support growth 507
18.5.3 REST OF LATIN AMERICA 514
18.6 MIDDLE EAST 522
18.6.1 GCC COUNTRIES 529
18.6.1.1 Saudi Arabia 536
18.6.1.1.1 Growing healthcare expenditure in Saudi Arabia to boost market growth 536
18.6.1.2 UAE 543
18.6.1.2.1 Collaborations to advance genome sequencing and market growth 543
18.6.1.3 Rest of GCC countries 549
18.6.2 REST OF MIDDLE EAST 557
18.7 AFRICA 565
18.7.1 GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET 565
19 COMPETITIVE LANDSCAPE 574
19.1 INTRODUCTION 574
19.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 574
19.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NGS MARKET 574
19.3 REVENUE ANALYSIS, 2021?2025 576
19.4 MARKET SHARE ANALYSIS, 2025 577
19.5 BRAND/PRODUCT COMPARISON 580
19.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 581
19.6.1 STARS 581
19.6.2 EMERGING LEADERS 581
19.6.3 PERVASIVE PLAYERS 581
19.6.4 PARTICIPANTS 581
19.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 583
19.6.5.1 Company footprint 583
19.6.5.2 Region footprint 584
19.6.5.3 Offering footprint 585
19.6.5.4 Application footprint 586
19.6.5.5 Technology footprint 587
19.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 588
19.7.1 PROGRESSIVE COMPANIES 588
19.7.2 RESPONSIVE COMPANIES 588
19.7.3 DYNAMIC COMPANIES 588
19.7.4 STARTING BLOCKS 589
19.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 590
19.7.5.1 Detailed list of key startups/SMEs 590
19.7.5.2 Competitive benchmarking of startups/SMEs 591
19.8 COMPANY VALUATION & FINANCIAL METRICS 592
19.8.1 COMPANY VALUATION 592
19.8.2 FINANCIAL METRICS 592
19.9 COMPETITIVE SCENARIO 593
19.9.1 PRODUCT LAUNCHES 593
19.9.2 DEALS 594
19.9.3 EXPANSIONS 595
?
20 COMPANY PROFILES 596
20.1 KEY PLAYERS 596
20.1.1 ILLUMINA, INC. 596
20.1.1.1 Business overview 596
20.1.1.2 Products/Services offered 597
20.1.1.3 Recent developments 600
20.1.1.3.1 Product launches 600
20.1.1.3.2 Deals 601
20.1.1.4 MnM view 602
20.1.1.4.1 Key strengths 602
20.1.1.4.2 Strategic choices 602
20.1.1.4.3 Weaknesses and competitive threats 602
20.1.2 THERMO FISHER SCIENTIFIC INC. 603
20.1.2.1 Business overview 603
20.1.2.2 Products/Services offered 604
20.1.2.3 Recent developments 607
20.1.2.3.1 Product launches 607
20.1.2.3.2 Deals 608
20.1.2.3.3 Expansions 609
20.1.2.4 MnM view 609
20.1.2.4.1 Key strengths 609
20.1.2.4.2 Strategic choices 609
20.1.2.4.3 Weaknesses and competitive threats 609
20.1.3 AGILENT TECHNOLOGIES, INC. 610
20.1.3.1 Business overview 610
20.1.3.2 Products/Services offered 611
20.1.3.3 Recent developments 613
20.1.3.3.1 Deals 613
20.1.3.3.2 Expansions 614
20.1.3.4 MnM view 614
20.1.3.4.1 Key strengths 614
20.1.3.4.2 Strategic choices 614
20.1.3.4.3 Weaknesses and competitive threats 614
20.1.4 F. HOFFMANN-LA ROCHE LTD. 615
20.1.4.1 Business overview 615
20.1.4.2 Products/Services offered 616
20.1.4.3 Recent developments 618
20.1.4.3.1 Product launches 618
20.1.4.3.2 Deals 618
20.1.4.3.3 Other developments 619
20.1.4.4 MnM view 619
20.1.4.4.1 Key strengths 619
20.1.4.4.2 Strategic choices 619
20.1.4.4.3 Weaknesses and competitive threats 619
20.1.5 QIAGEN 620
20.1.5.1 Business overview 620
20.1.5.2 Products/services offered 621
20.1.5.3 Recent developments 623
20.1.5.3.1 Deals 624
20.1.5.3.2 Expansions 625
20.1.5.4 MnM view 626
20.1.5.4.1 Key strengths 626
20.1.5.4.2 Strategic choices 626
20.1.5.4.3 Weaknesses and competitive threats 626
20.1.6 DANAHER CORPORATION 627
20.1.6.1 Business overview 627
20.1.6.2 Products/services offered 628
20.1.6.3 Recent developments 630
20.1.6.3.1 Product launches 630
20.1.6.3.2 Deals 631
20.1.6.3.3 Expansions 631
20.1.7 REVVITY 632
20.1.7.1 Business overview 632
20.1.7.2 Products/Services offered 633
20.1.7.3 Recent developments 635
20.1.7.3.1 Product launches 635
20.1.7.3.2 Deals 635
20.1.7.3.3 Expansions 636
20.1.8 EUROFINS SCIENTIFIC 637
20.1.8.1 Business overview 637
20.1.8.2 Products/services offered 638
20.1.8.3 Recent developments 638
20.1.8.3.1 Deals 638
20.1.9 PACBIO 639
20.1.9.1 Business overview 639
20.1.9.2 Products/Services offered 640
20.1.9.3 Recent developments 643
20.1.9.3.1 Product launches 643
20.1.9.3.2 Deals 643
20.1.9.3.3 Expansions 644
20.1.10 OXFORD NANOPORE TECHNOLOGIES PLC 645
20.1.10.1 Business overview 645
20.1.10.2 Products/Services offered 646
20.1.10.3 Recent developments 648
20.1.10.3.1 Deals 648
20.1.10.3.2 Expansions 649
20.1.11 TAKARA BIO INC. 650
20.1.11.1 Business overview 650
20.1.11.2 Products/Services offered 651
20.1.11.3 Recent developments 653
20.1.11.3.1 Deals 653
20.1.12 BGI GROUP 654
20.1.12.1 Business overview 654
20.1.12.2 Products/Services offered 654
20.1.13 BD 658
20.1.13.1 Business overview 658
20.1.13.2 Products/Services offered 659
20.1.13.3 Recent developments 660
20.1.13.3.1 Product launches 660
20.1.14 10X GENOMICS 661
20.1.14.1 Business overview 661
20.1.14.2 Products/Services offered 662
20.1.15 PROMEGA CORPORATION 665
20.1.15.1 Business overview 665
20.1.15.2 Products/Services offered 665
20.1.16 LGC LIMITED 666
20.1.16.1 Business overview 666
20.1.16.2 Products/Services offered 667
20.1.16.3 Recent developments 668
20.1.16.3.1 Deals 668
20.1.17 WUXI BIOLOGICS 669
20.1.17.1 Business overview 669
20.1.17.2 Products/Services offered 670
20.1.18 TECAN TRADING AG 671
20.1.18.1 Business overview 671
20.1.18.2 Products/Services offered 672
20.1.18.3 Recent developments 673
20.1.18.3.1 Deals 673
20.1.19 TWIST BIOSCIENCE 674
20.1.19.1 Business overview 674
20.1.19.2 Products/Services offered 675
20.1.19.3 Recent developments 676
20.1.19.3.1 Product launches 676
20.1.19.3.2 Deals 677
?
20.1.20 AZENTA US INC. 678
20.1.20.1 Business overview 678
20.1.20.2 Products/Services offered 679
20.1.20.3 Recent developments 680
20.1.20.3.1 Deals 680
20.2 OTHER PLAYERS 681
20.2.1 MGI TECH CO. LTD. 681
20.2.2 NOVOGENE CO., LTD. 683
20.2.3 NEW ENGLAND BIOLABS 684
20.2.4 GENSCRIPT 685
20.2.5 PSOMAGEN 685
20.2.6 ZYMO RESEARCH CORPORATION 686
20.2.7 HAMILTON COMPANY 687
20.2.8 NEOGENOMICS LABORATORIES 688
20.2.9 FULGENT GENETICS 689
20.2.10 SD BIOSENSOR, INC. 690
21 RESEARCH METHODOLOGY 691
21.1 RESEARCH DATA 691
21.1.1 SECONDARY DATA 691
21.1.1.1 Key data from secondary sources 691
21.1.2 PRIMARY DATA 692
21.1.2.1 Key data from primary sources 692
21.1.2.2 Key primary participants 693
21.1.2.3 Breakdown of primary interviews 693
21.1.2.4 Key industry insights 694
21.2 MARKET SIZE ESTIMATION 695
21.2.1 GLOBAL NEXT-GENERATION SEQUENCING MARKET ESTIMATION, 2025 695
21.2.2 SEGMENTAL MARKET SIZE ESTIMATION 697
21.3 MARKET GROWTH RATE PROJECTIONS 699
21.4 DATA TRIANGULATION 701
21.5 FACTOR ANALYSIS 702
21.6 RESEARCH ASSUMPTIONS 702
21.7 RESEARCH LIMITATIONS AND RISK ASSESSMENT 703
22 APPENDIX 705
22.1 DISCUSSION GUIDE 705
22.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 711
22.3 CUSTOMIZATION OPTIONS 713
22.4 RELATED REPORTS 713
22.5 AUTHOR DETAILS 714

ページTOPに戻る

List of Tables/Graphs

TABLE 1 NEXT-GENERATION SEQUENCING MARKET: INCLUSIONS & EXCLUSIONS 60
TABLE 2 IMPACT OF MARKET DYNAMICS 72
TABLE 3 NEXT-GENERATION SEQUENCING MARKET: PORTER’S FIVE FORCES 78
TABLE 4 NEXT-GENERATION SEQUENCING MARKET: ROLE OF PLAYERS IN ECOSYSTEM 85
TABLE 5 AVERAGE SELLING PRICE TREND OF PLATFORMS, BY KEY PLAYER,
2023?2025 (USD) 86
TABLE 6 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER,
2023?2025 (USD) 87
TABLE 7 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2025 (USD) 88
TABLE 8 AVERAGE SELLING PRICE TREND, BY REGION, 2023?2025 (USD) 89
TABLE 9 IMPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021?2025 (USD THOUSAND) 91
TABLE 10 IMPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021?2025 (TONS) 92
TABLE 11 EXPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021?2025 (USD THOUSAND) 93
TABLE 12 EXPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021?2025 (TONS) 94
TABLE 13 IMPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021?2025 (USD THOUSAND) 95
TABLE 14 IMPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021?2025 (TONS) 96
TABLE 15 EXPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021?2025 (USD THOUSAND) 97
TABLE 16 EXPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021?2025 (TONS) 98
TABLE 17 NEXT-GENERATION SEQUENCING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026?MARCH 2027 99
TABLE 18 RECIPROCAL TARIFF RATES ADJUSTED BY US 103
TABLE 19 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES 104
TABLE 20 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE 108
TABLE 21 KEY BUYING CRITERIA FOR PRODUCTS, BY END USER 108
TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112
TABLE 25 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113
TABLE 26 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015?2025 124
TABLE 27 KEY PATENTS, 2023?2025 125
TABLE 28 CASE STUDIES OF AI IMPLEMENTATION IN NEXT-GENERATION SEQUENCING MARKET 128
TABLE 29 CLIENT’S READINESS TO ADOPT AI-INTEGRATED SEQUENCING SOLUTIONS IN NEXT-GENERATION SEQUENCING MARKET 129
TABLE 30 NGS MARKET, BY OFFERING, 2024?2031 (USD MILLION) 131
TABLE 31 NGS PRODUCTS MARKET, BY REGION, 2024?2031 (USD MILLION) 132
TABLE 32 NORTH AMERICA: NGS PRODUCTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 132
TABLE 33 EUROPE: NGS PRODUCTS MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 132
TABLE 34 ASIA PACIFIC: NGS PRODUCTS MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 133
TABLE 35 LATIN AMERICA: NGS PRODUCTS MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 133
TABLE 36 MIDDLE EAST: NGS PRODUCTS MARKET, BY REGION, 2024?2031 (USD MILLION) 133
TABLE 37 GCC COUNTRIES: NGS PRODUCTS MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 134
TABLE 38 NGS SERVICES MARKET, BY REGION, 2024?2031 (USD MILLION) 135
TABLE 39 NORTH AMERICA: NGS SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 135
TABLE 40 EUROPE: NGS SERVICES MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 135
TABLE 41 ASIA PACIFIC: NGS SERVICES MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 136
TABLE 42 LATIN AMERICA: NGS SERVICES MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 136
TABLE 43 MIDDLE EAST: NGS SERVICES MARKET, BY REGION, 2024?2031 (USD MILLION) 136
TABLE 44 GCC COUNTRIES: NGS SERVICES MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 137
TABLE 45 NGS PRODUCTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 139
TABLE 46 NGS CONSUMABLES MARKET, BY REGION, 2024?2031 (USD MILLION) 140
TABLE 47 NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 140
TABLE 48 EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 141
TABLE 49 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 141
TABLE 50 LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 142
TABLE 51 MIDDLE EAST: NGS CONSUMABLES MARKET, BY REGION,
2024?2031 (USD MILLION) 142
TABLE 52 GCC COUNTRIES: NGS CONSUMABLES MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 142
TABLE 53 NGS CONSUMABLES MARKET, BY TYPE, 2024?2031 (USD MILLION) 143
TABLE 54 LIBRARY PREPARATION KITS & REAGENTS MARKET, BY REGION,
2024?2031 (USD MILLION) 144
TABLE 55 NORTH AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 145
TABLE 56 EUROPE: LIBRARY PREPARATION KITS & REAGENTS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 145
TABLE 57 ASIA PACIFIC: LIBRARY PREPARATION KITS & REAGENTS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 146
TABLE 58 LATIN AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 146
TABLE 59 MIDDLE EAST: LIBRARY PREPARATION KITS & REAGENTS MARKET,
BY REGION/REGION, 2024?2031 (USD MILLION) 146
TABLE 60 GCC COUNTRIES: LIBRARY PREPARATION KITS & REAGENTS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 147
TABLE 61 SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2024?2031 (USD MILLION) 148
TABLE 62 NORTH AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 148
TABLE 63 EUROPE: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 149
TABLE 64 ASIA PACIFIC: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 149
TABLE 65 LATIN AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 150
TABLE 66 MIDDLE EAST: SEQUENCING KITS & REAGENTS MARKET, BY REGION,
2024?2031 (USD MILLION) 150
TABLE 67 GCC COUNTRIES: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 150
TABLE 68 OTHER CONSUMABLES MARKET, BY REGION, 2024?2031 (USD MILLION) 151
TABLE 69 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 151
TABLE 70 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 152
TABLE 71 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 152
TABLE 72 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 153
TABLE 73 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY REGION,
2024?2031 (USD MILLION) 153
TABLE 74 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 153
TABLE 75 NGS PLATFORMS MARKET, BY REGION, 2024?2031 (USD MILLION) 154
TABLE 76 NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 154
TABLE 77 EUROPE: NGS PLATFORMS MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 155
TABLE 78 ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 155
TABLE 79 LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 156
TABLE 80 MIDDLE EAST: NGS PLATFORMS MARKET, BY REGION, 2024?2031 (USD MILLION) 156
TABLE 81 GCC COUNTRIES: NGS PLATFORMS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 156
TABLE 82 NGS PLATFORMS MARKET, BY TYPE, 2024?2031 (USD MILLION) 157
TABLE 83 SEQUENCING PLATFORMS MARKET, BY REGION, 2024?2031 (USD MILLION) 157
TABLE 84 NORTH AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 158
TABLE 85 EUROPE: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 158
TABLE 86 ASIA PACIFIC: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 159
TABLE 87 LATIN AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 159
TABLE 88 MIDDLE EAST: SEQUENCING PLATFORMS MARKET, BY REGION,
2024?2031 (USD MILLION) 159
TABLE 89 GCC COUNTRIES: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 160
TABLE 90 SEQUENCING PLATFORMS MARKET, BY TYPE, 2024?2031 (USD MILLION) 160
TABLE 91 ILLUMINA SEQUENCING PLATFORMS MARKET, BY TYPE,
2024?2031 (USD MILLION) 161
TABLE 92 ILLUMINA SEQUENCING PLATFORMS MARKET, BY REGION,
2024?2031 (USD MILLION) 161
TABLE 93 NOVASEQ (X/X PLUS) SYSTEMS MARKET, BY REGION, 2024?2031 (USD MILLION) 162
TABLE 94 MISEQ/MISEQ I100 SYSTEMS MARKET, BY REGION, 2024?2031 (USD MILLION) 163
TABLE 95 NEXTSEQ 1K/2K AND 550 SYSTEMS MARKET, BY REGION,
2024?2031 (USD MILLION) 164
TABLE 96 NOVASEQ 6000 SYSTEMS MARKET, BY REGION, 2024?2031 (USD MILLION) 165
TABLE 97 THERMO FISHER SCIENTIFIC SEQUENCING PLATFORMS MARKET, BY REGION, 2024?2031 (USD MILLION) 166
TABLE 98 PACBIO SEQUENCING PLATFORMS MARKET, BY REGION,
2024?2031 (USD MILLION) 166
TABLE 99 OXFORD NANOPORE TECHNOLOGIES SEQUENCING PLATFORMS MARKET,
BY REGION, 2024?2031 (USD MILLION) 170
TABLE 100 LIBRARY PREPARATION PLATFORMS MARKET, BY REGION,
2024?2031 (USD MILLION) 171
TABLE 101 NORTH AMERICA: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 172
TABLE 102 EUROPE: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 172
TABLE 103 ASIA PACIFIC: LIBRARY PREPARATION PLATFORMS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 173
TABLE 104 LATIN AMERICA: LIBRARY PREPARATION PLATFORMS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 173
TABLE 105 MIDDLE EAST: LIBRARY PREPARATION PLATFORMS MARKET, BY REGION/REGION, 2024?2031 (USD MILLION) 173
TABLE 106 GCC COUNTRIES: LIBRARY PREPARATION PLATFORMS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 174
TABLE 107 NGS BIOINFORMATICS TOOLS MARKET, BY REGION, 2024?2031 (USD MILLION) 175
TABLE 108 NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 175
TABLE 109 EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 176
TABLE 110 ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 176
TABLE 111 LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 177
TABLE 112 MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY REGION,
2024?2031 (USD MILLION) 177
TABLE 113 GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 177
TABLE 114 NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024?2031 (USD MILLION) 177
TABLE 115 DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION,
2024?2031 (USD MILLION) 179
TABLE 116 NORTH AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 179
TABLE 117 EUROPE: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 180
TABLE 118 ASIA PACIFIC: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 180
TABLE 119 LATIN AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 181
TABLE 120 MIDDLE EAST: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,
BY REGION, 2024?2031 (USD MILLION) 181
TABLE 121 GCC COUNTRIES: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 181
TABLE 122 DATA VISUALIZATION TOOLS MARKET, BY REGION, 2024?2031 (USD MILLION) 182
TABLE 123 NORTH AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 182
TABLE 124 EUROPE: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 183
TABLE 125 ASIA PACIFIC: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 183
TABLE 126 LATIN AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 184
TABLE 127 MIDDLE EAST: DATA VISUALIZATION TOOLS MARKET, BY REGION,
2024?2031 (USD MILLION) 184
TABLE 128 GCC COUNTRIES: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 184
TABLE 129 OTHER BIOINFORMATICS TOOLS MARKET, BY REGION, 2024?2031 (USD MILLION) 185
TABLE 130 NORTH AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 185
TABLE 131 EUROPE: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 186
TABLE 132 ASIA PACIFIC: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 186
TABLE 133 LATIN AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 187
TABLE 134 MIDDLE EAST: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 187
TABLE 135 GCC COUNTRIES: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 187
TABLE 136 NGS TECHNOLOGIES, BY COMPANY 189
TABLE 137 NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024?2031 (USD MILLION) 190
TABLE 138 NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION,
2024?2031 (USD MILLION) 191
TABLE 139 NORTH AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,
BY COUNTRY, 2024?2031 (USD MILLION) 191
TABLE 140 EUROPE: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 192
TABLE 141 ASIA PACIFIC: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 192
TABLE 142 LATIN AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 193
TABLE 143 MIDDLE EAST: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,
BY REGION, 2024?2031 (USD MILLION) 193
TABLE 144 GCC COUNTRIES: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 193
TABLE 145 NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2024?2031 (USD MILLION) 195
TABLE 146 NORTH AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2024?2031 (USD MILLION) 195
TABLE 147 EUROPE: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 196
TABLE 148 ASIA PACIFIC: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 196
TABLE 149 LATIN AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 197
TABLE 150 MIDDLE EAST: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2024?2031 (USD MILLION) 197
TABLE 151 GCC COUNTRIES: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 197
TABLE 152 NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION,
2024?2031 (USD MILLION) 198
TABLE 153 NORTH AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING,
BY COUNTRY, 2024?2031 (USD MILLION) 199
TABLE 154 EUROPE: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 199
TABLE 155 ASIA PACIFIC: NGS PLATFORMS MARKET FOR SMRT SEQUENCING,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 200
TABLE 156 LATIN AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 200
TABLE 157 MIDDLE EAST: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION, 2024?2031 (USD MILLION) 201
TABLE 158 GCC COUNTRIES: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 201
TABLE 159 NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION,
2024?2031 (USD MILLION) 202
TABLE 160 NORTH AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2024?2031 (USD MILLION) 203
TABLE 161 EUROPE: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 203
TABLE 162 ASIA PACIFIC: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 204
TABLE 163 LATIN AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 204
TABLE 164 MIDDLE EAST: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2024?2031 (USD MILLION) 205
TABLE 165 GCC COUNTRIES: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 205
TABLE 166 NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2024?2031 (USD MILLION) 206
TABLE 167 NORTH AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2024?2031 (USD MILLION) 206
TABLE 168 EUROPE: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 207
TABLE 169 ASIA PACIFIC: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 207
TABLE 170 LATIN AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 208
TABLE 171 MIDDLE EAST: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2024?2031 (USD MILLION) 208
TABLE 172 GCC COUNTRIES: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 208
TABLE 173 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY WORKFLOW,
2024?2031 (USD MILLION) 210
TABLE 174 NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2024?2031 (USD MILLION) 211
TABLE 175 NORTH AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024?2031 (USD MILLION) 211
TABLE 176 EUROPE: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024?2031 (USD MILLION) 212
TABLE 177 ASIA PACIFIC: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024?2031 (USD MILLION) 212
TABLE 178 LATIN AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024?2031 (USD MILLION) 213
TABLE 179 MIDDLE EAST: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2024?2031 (USD MILLION) 213
TABLE 180 GCC COUNTRIES: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024?2031 (USD MILLION) 213
TABLE 181 NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION, 2024?2031 (USD MILLION) 215
TABLE 182 NORTH AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024?2031 (USD MILLION) 215
TABLE 183 EUROPE: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024?2031 (USD MILLION) 216
TABLE 184 ASIA PACIFIC: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024?2031 (USD MILLION) 216
TABLE 185 LATIN AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024?2031 (USD MILLION) 217
TABLE 186 MIDDLE EAST: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION, 2024?2031 (USD MILLION) 217
TABLE 187 GCC COUNTRIES: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024?2031 (USD MILLION) 217
TABLE 188 NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2024?2031 (USD MILLION) 219
TABLE 189 NORTH AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024?2031 (USD MILLION) 219
TABLE 190 EUROPE: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024?2031 (USD MILLION) 220
TABLE 191 ASIA PACIFIC: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024?2031 (USD MILLION) 220
TABLE 192 LATIN AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024?2031 (USD MILLION) 221
TABLE 193 MIDDLE EAST: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2024?2031 (USD MILLION) 221
TABLE 194 GCC COUNTRIES: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024?2031 (USD MILLION) 221
TABLE 195 NGS PRODUCTS MARKET, BY END USER, 2024?2031 (USD MILLION) 223
TABLE 196 NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024?2031 (USD MILLION) 224
TABLE 197 NORTH AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024?2031 (USD MILLION) 224
TABLE 198 EUROPE: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 225
TABLE 199 ASIA PACIFIC: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 225
TABLE 200 LATIN AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 226
TABLE 201 MIDDLE EAST: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024?2031 (USD MILLION) 226
TABLE 202 GCC COUNTRIES: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 226
TABLE 203 NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024?2031 (USD MILLION) 228
TABLE 204 NORTH AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024?2031 (USD MILLION) 228
TABLE 205 EUROPE: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 229
TABLE 206 ASIA PACIFIC: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 229
TABLE 207 LATIN AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 230
TABLE 208 MIDDLE EAST: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024?2031 (USD MILLION) 230
TABLE 209 GCC COUNTRIES: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 230
TABLE 210 NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2024?2031 (USD MILLION) 231
TABLE 211 NORTH AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024?2031 (USD MILLION) 232
TABLE 212 EUROPE: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 232
TABLE 213 ASIA PACIFIC: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 233
TABLE 214 LATIN AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 233
TABLE 215 MIDDLE EAST: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2024?2031 (USD MILLION) 233
TABLE 216 GCC COUNTRIES: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 234
TABLE 217 NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION,
2024?2031 (USD MILLION) 235
TABLE 218 NORTH AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024?2031 (USD MILLION) 235
TABLE 219 EUROPE: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 236
TABLE 220 ASIA PACIFIC: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 236
TABLE 221 LATIN AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 237
TABLE 222 MIDDLE EAST: NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024?2031 (USD MILLION) 237
TABLE 223 GCC COUNTRIES: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 237
TABLE 224 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 239
TABLE 225 SEQUENCING SERVICES MARKET, BY REGION, 2024?2031 (USD MILLION) 240
TABLE 226 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 240
TABLE 227 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 241
TABLE 228 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 241
TABLE 229 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 242
TABLE 230 MIDDLE EAST: SEQUENCING SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 242
TABLE 231 GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 242
TABLE 232 SEQUENCING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 243
TABLE 233 EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY REGION, 2024?2031 (USD MILLION) 244
TABLE 234 NORTH AMERICA: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 244
TABLE 235 EUROPE: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 245
TABLE 236 ASIA PACIFIC: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 245
TABLE 237 LATIN AMERICA: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 246
TABLE 238 MIDDLE EAST: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY REGION, 2024?2031 (USD MILLION) 246
TABLE 239 GCC COUNTRIES: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 246
TABLE 240 RNA SEQUENCING SERVICES MARKET, BY REGION, 2024?2031 (USD MILLION) 247
TABLE 241 NORTH AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 247
TABLE 242 EUROPE: RNA SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 248
TABLE 243 ASIA PACIFIC: RNA SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 248
TABLE 244 LATIN AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 249
TABLE 245 MIDDLE EAST: RNA SEQUENCING SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 249
TABLE 246 GCC COUNTRIES: RNA SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 249
TABLE 247 DE NOVO SEQUENCING SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 250
TABLE 248 NORTH AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 251
TABLE 249 EUROPE: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 251
TABLE 250 ASIA PACIFIC: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 252
TABLE 251 LATIN AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 252
TABLE 252 MIDDLE EAST: DE NOVO SEQUENCING SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 252
TABLE 253 GCC COUNTRIES: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 253
TABLE 254 CHIP SEQUENCING SERVICES MARKET, BY REGION, 2024?2031 (USD MILLION) 254
TABLE 255 NORTH AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 254
TABLE 256 EUROPE: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 255
TABLE 257 ASIA PACIFIC: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 255
TABLE 258 LATIN AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 256
TABLE 259 MIDDLE EAST: CHIP SEQUENCING SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 256
TABLE 260 GCC COUNTRIES: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 256
TABLE 261 WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 257
TABLE 262 NORTH AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 258
TABLE 263 EUROPE: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 258
TABLE 264 ASIA PACIFIC: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 259
TABLE 265 LATIN AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 259
TABLE 266 MIDDLE EAST: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2024?2031 (USD MILLION) 259
TABLE 267 GCC COUNTRIES: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 260
TABLE 268 METHYL SEQUENCING SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 261
TABLE 269 NORTH AMERICA: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 261
TABLE 270 EUROPE: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 262
TABLE 271 ASIA PACIFIC: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 262
TABLE 272 LATIN AMERICA: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 263
TABLE 273 MIDDLE EAST: METHYL SEQUENCING SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 263
TABLE 274 GCC COUNTRIES: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 263
TABLE 275 OTHER SEQUENCING SERVICES MARKET, BY REGION, 2024?2031 (USD MILLION) 264
TABLE 276 NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 265
TABLE 277 EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 265
TABLE 278 ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 266
TABLE 279 LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 266
TABLE 280 MIDDLE EAST: OTHER SEQUENCING SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 266
TABLE 281 GCC COUNTRIES: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 267
TABLE 282 PRESEQUENCING SERVICES MARKET, BY REGION, 2024?2031 (USD MILLION) 267
TABLE 283 NORTH AMERICA: PRESEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 268
TABLE 284 EUROPE: PRESEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 268
TABLE 285 ASIA PACIFIC: PRESEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 269
TABLE 286 LATIN AMERICA: PRESEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 269
TABLE 287 MIDDLE EAST: PRESEQUENCING SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 269
TABLE 288 GCC COUNTRIES: PRESEQUENCING SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 270
TABLE 289 PRESEQUENCING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 270
TABLE 290 LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2024?2031 (USD MILLION) 271
TABLE 291 NORTH AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 271
TABLE 292 EUROPE: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 272
TABLE 293 ASIA PACIFIC: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 272
TABLE 294 LATIN AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 273
TABLE 295 MIDDLE EAST: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2024?2031 (USD MILLION) 273
TABLE 296 GCC COUNTRIES: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 273
TABLE 297 SAMPLE PREPARATION SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 274
TABLE 298 NORTH AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 275
TABLE 299 EUROPE: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 275
TABLE 300 ASIA PACIFIC: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 276
TABLE 301 LATIN AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 276
TABLE 302 MIDDLE EAST: SAMPLE PREPARATION SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 276
TABLE 303 GCC COUNTRIES: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 277
TABLE 304 QUALITY CONTROL SERVICES MARKET, BY REGION, 2024?2031 (USD MILLION) 277
TABLE 305 NORTH AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 278
TABLE 306 EUROPE: QUALITY CONTROL SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 278
TABLE 307 ASIA PACIFIC: QUALITY CONTROL SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 279
TABLE 308 LATIN AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 279
TABLE 309 MIDDLE EAST: QUALITY CONTROL SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 279
TABLE 310 GCC COUNTRIES: QUALITY CONTROL SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 280
TABLE 311 BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 281
TABLE 312 NORTH AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 281
TABLE 313 EUROPE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 282
TABLE 314 ASIA PACIFIC: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 282
TABLE 315 LATIN AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 283
TABLE 316 MIDDLE EAST: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY REGION, 2024?2031 (USD MILLION) 283
TABLE 317 GCC COUNTRIES: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 283
TABLE 318 BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 284
TABLE 319 DATA ANALYSIS SERVICES MARKET, BY REGION, 2024?2031 (USD MILLION) 285
TABLE 320 NORTH AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 285
TABLE 321 EUROPE: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 286
TABLE 322 ASIA PACIFIC: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 286
TABLE 323 LATIN AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 287TABLE 324 MIDDLE EAST: DATA ANALYS